HCA Healthcare (HCA) Cash & Equivalents (2010 - 2026)

HCA Healthcare (HCA) has 17 years of Cash & Equivalents data on file, last reported at $940.0 million in Q1 2026.

• Quarterly Cash & Equivalents fell 11.32% year-over-year to $940.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $940.0 million (down 11.32% YoY) and the FY2025 annual result came in at $1.0 billion, down 46.2% from the prior year.
• Cash & Equivalents retreated to $940.0 million in Q1 2026 per HCA's latest filing, from $1.0 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $2.9 billion in Q3 2024 and bottomed at $493.0 million in Q2 2022.
• The 5-year median for Cash & Equivalents is $939.0 million (2025), against an average of $1.1 billion.
• The widest annual swing landed in 2024, when Cash & Equivalents jumped 224.13%; it then slumped 65.48% in 2025.
• Tracing HCA's Cash & Equivalents over 5 years: stood at $908.0 million in 2022, then rose by 2.97% to $935.0 million in 2023, then surged by 106.74% to $1.9 billion in 2024, then tumbled by 46.2% to $1.0 billion in 2025, then dropped by 9.62% to $940.0 million in 2026.
• Per Business Quant, the three latest HCA Cash & Equivalents figures stand at $940.0 million (Q1 2026), $1.0 billion (Q4 2025), and $997.0 million (Q3 2025).

Peer Comparison